Enigma Biomedical USA (EB USA) today announced that the Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for MK-6240 (florquinitau F-18), their Tau Positron Emission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback